Bleakley Financial Group LLC Buys New Shares in Agilent Technologies, Inc. $A

Bleakley Financial Group LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) in the 1st quarter, Holdings Channel reports. The firm purchased 16,543 shares of the medical research company’s stock, valued at approximately $1,886,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Massachusetts Financial Services Co. MA boosted its holdings in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. State Street Corp grew its stake in shares of Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC increased its holdings in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after buying an additional 25,139 shares during the last quarter. Morgan Stanley increased its holdings in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after buying an additional 692,202 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Agilent Technologies in the 4th quarter worth $549,158,000.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Wells Fargo & Company reduced their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Royal Bank Of Canada began coverage on Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target for the company. TD Cowen raised their price objective on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. HSBC reduced their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Finally, Jefferies Financial Group initiated coverage on Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $159.35.

Get Our Latest Research Report on A

Agilent Technologies Trading Up 1.1%

Shares of A opened at $136.14 on Friday. The stock’s 50-day moving average is $127.17 and its two-hundred day moving average is $125.58. The stock has a market cap of $38.45 billion, a PE ratio of 27.34, a P/E/G ratio of 2.40 and a beta of 1.25. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62.

Agilent Technologies (NYSE:AGet Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.